AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,172 | -19.7% | 5,575 | -15.0% | 0.00% | – |
| Q2 2023 | $82,435 | -62.8% | 6,559 | -67.1% | 0.00% | – |
| Q1 2023 | $221,311 | +1126.4% | 19,956 | +1250.2% | 0.00% | – |
| Q4 2022 | $18,046 | +20.3% | 1,478 | 0.0% | 0.00% | – |
| Q3 2022 | $15,000 | -16.7% | 1,478 | -14.4% | 0.00% | – |
| Q2 2022 | $18,000 | -28.0% | 1,726 | -35.4% | 0.00% | – |
| Q1 2022 | $25,000 | -99.3% | 2,670 | -99.2% | 0.00% | -100.0% |
| Q4 2021 | $3,762,000 | -7.9% | 325,863 | -23.8% | 0.01% | -14.3% |
| Q3 2021 | $4,084,000 | -7.5% | 427,747 | -6.6% | 0.01% | 0.0% |
| Q2 2021 | $4,414,000 | +118.0% | 458,124 | +123.3% | 0.01% | +75.0% |
| Q1 2021 | $2,025,000 | -67.3% | 205,115 | -23.5% | 0.00% | -66.7% |
| Q4 2020 | $6,191,000 | +79.4% | 268,263 | +9.7% | 0.01% | +71.4% |
| Q3 2020 | $3,450,000 | +11.7% | 244,480 | +19.3% | 0.01% | 0.0% |
| Q2 2020 | $3,090,000 | +17.7% | 204,898 | -27.9% | 0.01% | 0.0% |
| Q1 2020 | $2,625,000 | -26.0% | 284,110 | -22.1% | 0.01% | 0.0% |
| Q4 2019 | $3,548,000 | +116.9% | 364,710 | +78.9% | 0.01% | +133.3% |
| Q3 2019 | $1,636,000 | +885.5% | 203,902 | +1393.2% | 0.00% | – |
| Q3 2018 | $166,000 | -77.4% | 13,655 | -71.0% | 0.00% | -100.0% |
| Q2 2018 | $735,000 | +2.9% | 47,065 | -1.0% | 0.00% | +100.0% |
| Q1 2018 | $714,000 | -40.7% | 47,536 | -42.0% | 0.00% | -50.0% |
| Q4 2017 | $1,205,000 | -40.7% | 82,023 | -39.1% | 0.00% | -33.3% |
| Q3 2017 | $2,032,000 | +77.9% | 134,698 | +18.7% | 0.00% | +50.0% |
| Q2 2017 | $1,142,000 | +32.0% | 113,483 | -6.5% | 0.00% | 0.0% |
| Q1 2017 | $865,000 | +1501.9% | 121,338 | +1004.9% | 0.00% | – |
| Q4 2016 | $54,000 | – | 10,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |